Virus Particle Release

Virus particle release is the stage of the viral life cycle in which newly assembled virions leave an infected cell to spread to additional host cells. Release occurs through mechanisms such as cell lysis, which ruptures the plasma membrane, or budding, in which enveloped virions acquire a lipid membrane as they exit through the host cell surface. The timing and efficiency of release influence viral transmission, tissue damage, and infection progression. Studying these processes helps researchers understand host–virus interactions, identify targets for antiviral therapies, and develop methods for measuring viral replication in cell culture.

Virus Particle Release - Related Videos

Research

JoVE EoE - Immunopathology

A Technique for the Generation of Influenza Virus-Like Particles via a Mammalian System

0 Views •

2025

This video demonstrates the generation of influenza virus-like particles (VLPs) in a mammalian system. Upon expressing three eukaryotic expression vectors — encoding different viral structural proteins — in suitable mammalian host cells, the expressed viral proteins self-assemble into VLPs on the host plasma membrane and release via budding from the cell surface.

Production and Purification of Recombinant Hepatitis B Virus Particles

0 Views •

2026

Source: Nishitsuji, H., et al. Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle. J. Vis. Exp. (2017)This video demonstrates the production and purification of recombinant Hepatitis B virus particles, enabling safe, replication-deficient viral preparations for studying early infection events and for high-throughput antiviral drug screening applications.

Expression and Purification of Virus-like Particles for Vaccination

0 Views •

Cited by 27 •

2016

Here, we present a protocol for synthesizing virus-like particles using either baculovirus or mammalian expression systems, and ultracentrifugation purification. This highly customizable approach is used to identify viral antigens as vaccine targets in a safe and flexible manner.

Production of Virus-like Particles in Engineered E. coli

0 Views •

2026

Source: Chen, Z., et al. Making Conjugation-induced Fluorescent PEGylated Virus-like Particles by Dibromomaleimide-disulfide Chemistry. J. Vis. Exp. (2018)This video demonstrates the method for the controlled expression of the bacteriophage Qβ coat protein in engineered E. coli. The resulting proteins self-assemble into virus-like particles, which are harvested for downstream bioconjugation.

Harvesting Hepatitis E Virus Particles from Human Liver Cancer Cells

0 Views •

2026

Source: Meister, T. L., et al. A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks. J. Vis. Exp. (2020).This video demonstrates the process of isolating hepatitis E virus (HEV) particles from transfected human hepatocellular carcinoma cells. Extracellular viral particles are collected from filtered supernatants, while intracellular particles are released by subjecting the cells to repeated freeze-thaw cycles. The lysate is centrifuged, and the supernatant containing HEV...

View All Results

FAQs

Related Topics